Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 22, 2015 5:16 AM ET

Life Sciences Tools and Services

Company Overview of MPI Research, Inc.

Company Overview

MPI Research, Inc. provides preclinical and early clinical services to agricultural, environmental science, biopharmaceutical, medical device, animal health, and chemical industries. It offers drug safety evaluation/preclinical solutions research services in the areas of general toxicology, infusion toxicology, developmental and reproductive toxicology, safety pharmacology, neurobehavioral sciences, and anatomic pathology/clinical pathology; and discovery services in drug metabolism and pharmacokinetic, in vitro service, in vivo model, molecular imaging, metabolic disease, cardiovascular, orthopaedic, renal, neuroscience, inflammation, infectious disease, oncology, and ophthalmology areas. T...

54943 North Main Street

Mattawan, MI 49071

United States

Founded in 1995

Phone:

269-668-3336

Fax:

269-668-4151

Key Executives for MPI Research, Inc.

Chairman and Chief Executive Officer
Age: 68
Chief Financial Officer and Executive Vice President
Age: 54
Senior Vice President of Drug Safety & Discovery and Senior Principal Study Director
Chief of Staff at Institutional Animal Care & Use Committee Chair
Chief Information Officer
Compensation as of Fiscal Year 2014.

MPI Research, Inc. Key Developments

MPI Research, Inc. Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-19-2014 03:50 PM

MPI Research, Inc. Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-19-2014 03:50 PM. Venue: Washington State Convention Center, Seattle, Washington, United States.

MPI Research, inviCRO, and 3D Imaging Announce New Translational Imaging Center to Speed Drug Development, Lower Costs

MPI Research, inviCRO, and 3D Imaging formally announced the name of their new advanced imaging center being built at the MPI Research headquarters in Mattawan, Mich. A joint partnership by the three organizations, the Translational Imaging Center, is the first resource for the drug development community to combine molecular imaging, autoradiography, and animal modeling with an onsite cyclotron, vivarium, and advanced image analytics. When completed in early spring, the Center will have the unique ability to efficiently translate preclinical data to clinical data, yielding critical insights capable of accelerating decisions, discoveries and innovation. As a result, drug developers will have access to imaging, radiochemistry, and informatics solutions to position their teams to make faster, better informed decisions regarding a drug candidate's potential. The 10,000-square-foot, two-story Translational Imaging Center will leverage the distinct and complementary strengths of each partner, including inviCRO's molecular imaging informatics team, 3D Imaging's radiopharmaceutical group, and the comprehensive CRO-based services of MPI Research.

MPI Research Names D. Thomas Tom Oakley as President and Chief Operating Officer

MPI Research announced that D. Thomas Tom Oakley has been appointed as President and Chief Operating Officer. Tom recently joined the company as Executive Vice President of Preclinical Operations. Oakley is an eminent senior executive with over 30 years of domestic and international strategic and operational leadership experience in major contract research organizations, industrial and consumer product businesses, and the United States Army. He most recently was President and CEO of ChanTest Corporation. Prior to ChanTest, Oakley was the President and CEO of Bridge Laboratories.

Similar Private Companies By Industry

Company Name Region
10X Technologies, Inc. United States
Thermo Iec Inc. United States
Diagnostic Oncology CRO, Inc. United States
ABT Molecular Imaging, Inc. United States
Ariadne Genomics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Bankruptcy
March 2, 2015
AtheroNova Operations, Inc.
Merger/Acquisition
October 27, 2014
Jasper Clinical Research & Development, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MPI Research, Inc., please visit www.mpiresearch.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.